DONALD W. SMITH, Ph.D.
Whether to use Bacillus Calmette-Guérin (BCG) vaccination as a means of tuberculosis control in high-risk populations in the United States is controversial. The most frequently cited arguments for not using BCG in these groups include: the problem is not of sufficient magnitude; the vaccine is not effective; the vaccine is not safe; and the attendant tuberculin conversion destroys the effectiveness of the tuberculin test as a case-finding tool. The validity of these arguments is challenged, and it is concluded that BCG vaccination should be recommended for high-risk groups in the United States.
Learn more about subscription options.
Register Now for a free account.
SMITH DW. Why Not Vaccinate Against Tuberculosis. Ann Intern Med. 1970;72:419–422. doi: 10.7326/0003-4819-72-3-419
Download citation file:
Published: Ann Intern Med. 1970;72(3):419-422.
Infectious Disease, Mycobacterial Infections.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only